SPRY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ARS Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 8.5 USD 4.04% Market Closed

Market Cap: $844.1m

	ARS Pharmaceuticals Inc NASDAQ:SPRY	US
	Power Finance Corporation Ltd NSE:PFC	IN
	Suncor Energy Inc TSX:SU	CA

Profitability Summary

ARS Pharmaceuticals Inc's profitability score is 12/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Sustainable 3Y Average Gross Margin

48%

Negative Operating Margin

-213%

Negative 3Y Average Operating Margin

-78 503%

Operating Margin is Increasing

-2 204% > -213%

Negative Net Margin

-203%

Negative 3Y Average Net Margin

-62 962%

Net Margin is Increasing

-1 866% > -203%

Negative Free Cash Flow Margin

-203%

Negative 3Y Average Free Cash Flow Margin

-68 182%

Free Cash Flow Margin is Increasing

-2 450% > -203%

Negative ROE

-92%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2 124%

Declining ROIC

-104% > -501%

View All

Hide

Collapse

12 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Sustainable 3Y Average Gross Margin

48%

Negative Operating Margin

-213%

Negative 3Y Average Operating Margin

-78 503%

Operating Margin is Increasing

-2 204% > -213%

Negative Net Margin

-203%